Polyoma virus complementary RNA, synthesized in vitro by using highly purified Escherichia coli RNA polymerase and nondefective form I polyoma DNA, was translated in a wheat germ cell-free system. Polypeptides were synthesized that comigrated on sodium dodecyl sulfate-polyacrylamide gels with the polyoma capsid proteins VP1 and VP2, although most of the cell-free products were of smaller molecular weights. The VP1-size protein specifically immunoprecipitated with anti-polyoma virus serum, and upon digestion by trypsin yielded [35S]methionine-labeled tryptic peptides that co-chromatographed with the [3H]methionine-labeled tryptic peptides of virion-derived VP1 on both cationexchange and anion-exchange resins. The VP2-size in vitro product contained all the virion VP2 methionine-labeled tryptic peptides, as shown by cation-and anion-exchange chromatography and two-dimensional fingerprinting on cellulose. We conclude that full-length polyoma VP1 and VP2 are synthesized in response to complementary RNA and consequently that the viral capsid proteins VP1, VP2, and VP3 are entirely virus coded.
The small DNA tumor virus, polyoma, is studied as a model system for eucaryotic DNA replication, for RNA transcription and translation, and for cellular transformation. Genetically, the virus contains a small amount of information encoded in double-stranded, closed circular DNA with a molecular weight of 3.6 x 106. The virus stably transforms certain cell lines and in others successfully replicates to produce progeny. This wide spectrum of biological effects must result in part from the interaction of the viral gene products with the host cell. As a prelude to understanding this interaction, the virus-coded polypeptides of polyoma need to be identified.
Most viruses encode the genetic information for some or all of their structural proteins. The polyoma virus particle contains seven polypeptides (12, 16, 19, 30) . The major coat polypeptide (VP1) has a molecular weight of 45,000 and is present at approximately five to six times the amount of two minor virion polypeptides of molecular weights 34 ,000 (VP2) and 23 ,000 (VP3). The virus also contains an 86,000-molecularweight polypeptide (VP0) that is a dimer of VP1 (11, 16) cell-derived histones (9, 10) . VP3 is related to VP2 because all of its tryptic peptides can be found in a digest of VP2 (9, 14, 16) . VP1 and VP2 are probably unique because they share few, if any, tryptic peptides.
The productive infection cycle of polyoma virus can be divided into two temporal phases. Before DNA replication, the cytoplasm contains a viral RNA that sediments at 20S (22, 37) . It is complementary to about 48% of the "E" strand of polyoma DNA, extending clockwise from unit 72 to 25 (22) on the physical map (15) . The only protein detected so far whose appearance is coincident with this early RNA is the polyoma T antigen (data summarized in reference 36). After the initiation of DNA replication, two new viral RNAs can be found in the cytoplasm, a major species that sediments at 16S and a minor species that sediments at 19S (4). These RNAs are complementary to the "L" strand of polyoma DNA (22 The question as to whether polyoma DNA integrates into the host chromosome during a productive infection is still not resolved (7, 20, 39 (23) with a broad peak at 35S, ranging from 22S to 45S (Fig. 1) . Thus, the majority of the cRNA molecules contained a complete copy of the L strand of polyoma DNA, i.e., the late mRNA sequences and those sequences complementary to early mRNA.
In vitro translation of polyoma cRNA. The wheat germ cell-free system was maximized for amino acid incorporation in response to polyoma cRNA. At an RNA concentration of 20 to 60 ,ug/ml, the optimal ionic conditions are 1.5 mM Mg2" and 40 mM K+. The cell-free product, when fractionated on SDS-polyacrylamide gels, appeared heterogeneous in size, ranging in molecular weight from 10,000 to 50,000, with the majority of the product less than 25,000 (Fig.  2b) . Two of the polypeptides synthesized in vitro comigrated with the polyoma structural proteins VP1 and VP2 ( Fig. 2a and b) . The polypeptide that comigrates with VP1 is precipitable with antiserum (38) directed against polyoma virions (Fig. 2c ). These data imply that polyoma cRNA can direct the synthesis of the polyoma capsid proteins VP1 and VP2. This possibility was further tested by comparing the tryptic peptides peptides and are unique to their parent proteins.
When the cell-free product that comigrates with VP1 was compared with authentic VP1 by cation-exchange chromatography, the elution patterns were identical (Fig. 3B ). There was no material in the position of the VP2-specific peak a or any shoulder on peak d. The peptide elution pattern obtained when the tryptic digest of the VP2-size cell-free product was co-chromatographed with authentic VP1 is more (38) , including 7.5 ,ul of wheat germ extract, 15 mM N-2-hydroxyethyl piperazine-N'-2-ethanesulfonic acid (pH 7.0), 40 mM KCI, 1.5 mM MgCl2, 2 mM2-mercaptoethanol, 1 mMATP, 0.2 mM GTP, 10 mM creatine phosphate, 50 tLM spermine, 250 pM spermidine, and 1 mM dithiothreitol. A total of 19 unlabeled amino acids, omitting methionine, were added to 200 LM, and P5SJmethionine was added at 500 ,uCi/ml. After a 3-h incubation at 220C, the products were analyzed by SDS-polyacrylamide electrophoresis followed by autoradiography. comigrates on SDS-polyacrylamide gels with virion VPJ labeled with f45SJmethionine, was applied to a cation column (B) and an anion column (E). A mixture of the tryptic peptides of virion VPI labeled with
[fH]methionine and the polypeptide synthesized with polyoma cRNA as message, uhich comigrates on SDSpolyacrylamide gels with virion VP2 labeled with ["S]methionine, was applied to a cation column (C) and an anion column (F). (Fig. 3C ). There were [;j5S]methionine-containing peptides at positions a, b, c, d, and e, with c appearing as a shoulder on the leading edge of peak d. These data indicate that polypeptides from this region of the gel include full-length polyoma VP2, because material chromatographing in the VP2-specific positions, a and c, was present in the tryptic digest. In addition, the (ii) Anion-exchange chromatography. Anion-exchange chromatography was also used to compare the methionine-containing tryptic peptides of VP1 and VP2 with their in vitro counterparts synthesized in response to polyoma cRNA (Fig. 3D) . In the digest of the two proteins from purified virions, about 8 peaks from VP1 and 10 peaks from VP2 were detected. Of these, the three peaks marked x, y, and z were well separated from the rest and were unique to VP2.
When a tryptic digest of virion protein VP1 and the cRNA-directed product of VP1 size were chromatographed together, their peaks were virtually superimposable (Fig. 3E) . The column profile of the digest of viral VP1 and the in vitro-synthesized VP2-size polypeptide shows that the three VP2-specific peaks (x, y, and z) were present (Fig. 3F ) in addition to material co-chromatographing with the major VP1-specific peaks. Peaks x, y, and z were not present in the digest of the cell-free product corresponding in size to VPI. Thus, the anion-exchange chromatography data also indicate that authentic VP1 and VP2 are made in response to polyoma cRNA, but that the VP2-size cell-free product contains, in addition, fragments of VP1.
(iii) Two-dimension fingerprints on cellulose. To were compared with a digest of the in vitrosynthesized product that comigrates on gels with VP2 by two-dimensional peptide mapping on cellulose. The peptides were first separated by electrophoresis at pH 2.1 and then by chromatography (38) . The characteristic fingerprints of polyoma VP1 and VP2 are shown in Fig. 4A and B, respectively. VP2 contained two major methionine peptides that were unique. The peptide fingerprints of the VP2-size in vitro product made in response to polyoma cRNA contained peptides that migrated in the position of both the VP2 characteristic peptides (Fig. 4C) . Their identity was confirmed by mixing a digest of VP2 from purified virions with a similar digest of the VP2-size cell-free product (Fig. 4D) . The major virion VP2-specific spots comigrated with two of the in vitro peptides, these spots having become more intense relative to the other peptides. The digest of the VP2-size cell-free product also contained several additional peptides that migrated as VP1-specific peptides. Indeed, when digests of virion-derived VP1 and VP2 were mixed and fractionated, the resulting peptide map (Fig. 4E) was very similar to that of the VP2-size cell-free product. A tracing of the fingerprint in Fig. 4C is shown in Fig. 4F , indicating the origin of the peptides in the cell-free product.
Since the bulk of the cell-free product synthesized with polyoma cRNA as message was smaller than either VP1 or VP2, we also examined this material. Two-dimensional tryptic peptide analysis of the trichloroacetic acid-insoluble material in an unfractionated reaction mixture (Fig. 2b) and of the major polypeptide synthesized in vitro that has a molecular weight of about 22 ,000 and migrates slightly faster than polyoma VP3 (Fig. 2b) showed that both contained predominantly VP1-derived peptides (data not shown). The finding (Fig. 2c) that several of the smaller polypeptides were immunoprecipitated to a greater extent by the anti-VP1 serum than by the control serum (Fig. 2d ) also suggests that they are related to VP1. Thus, the cell-free product contains predominantly fragments of VP1.
This analysis of the polypeptides made in response to polyoma cRNA indicates that the cell-free product includes proteins similar to the authentic capsid proteins VPI and VP2 in gel mobility, in [35S]methionine tryptic peptide content, and, in the case of VP1, in antigenic properties. We conclude that those two virion proteins are synthesized in vitro and, consequently, that both are entirely virus coded.
DISCUSSION
This work shows that polyoma cRNA can direct the synthesis in vitro of polypeptides apparently identical to the coat proteins VP1 and VP2. Because polyoma cRNA corresponds in sequence to a transcript of the L strand of polyoma DNA, the data imply that the two proteins are the products of the late genes. Furthermore, since the cRNA was synthesized by using highly purified nondefective viral DNA as template, the data also suggest that the two proteins are entirely virus coded, at least as judged by analysis of their methionine-containing tryptic peptides.
Data from other laboratories are also consistent with the above conclusions. All the tryptic peptides in polyoma virus VP3 can also be found in VP2 (9, 14, 16) , implying that all of VP3 and part of VP2 are derived from the same sequence of viral DNA. The sum of the molecular weights of VP1 and VP2 indicates that about 40% of the genome codes for these three capsid proteins. This is consistent with the late region comprising 43% of the viral DNA (22) and with the demonstration that the late 19S RNA translates in vitro into VP2 and the late 16S RNA into VP1 (34) . Also consistent with this conclusion is ,J. vllul.. Award, London, 1977) . A second conclusion from this work is that polyoma cRNA is translatable. This was not obvious as cRNA differs from normal mRNA's in several respects, as follows. Polyoma cRNA is probably not capped. This is suggested since (i) an activity capable of capping RNA is not known to be present in the highly purified E. coli transcription system used to synthesize the cRNA; (ii) S-adenosylhomocysteine, an inhibitor of cap methylation in the wheat germ cell-free system (3), does not inhibit translation of cRNA in vitro (our unpublished data); and (iii) the presence of m7Gp, which under some conditions specifically inhibits the in vitro translation of capped mRNA's (5, 17), does not inhibit the translation of either polyoma cRNA or encephalomyocarditis RNA, but does inhibit polyoma mRNA translation (R. Kamen, T. Wheeler, and A. E. Smith, submitted for publication). Polyoma cRNA also differs from mRNA in that it is probably not polyadenylated. Furthermore, it has a wide range of molecular weights (Fig. 1) , most of which correspond to molecules considerably larger than the 19S and 16S cytoplasmic mRNA species (22 Fig. 2b , the bulk of the product is less than 25,000 daltons.
The differences in the translation of cRNA, nuclear RNA, and mRNA perhaps reflect the importance of the sequences and structures adjacent to an initiation site in determining the efficiency with which a gene will be translated into protein. We do not know why so many ribosomes terminate synthesis prematurely to produce fragments of viral proteins or why such premature termination yields seemingly discrete-size polypeptides. We have obtained a similar result in translating SV40 cRNA which contains the early mRNA sequences. The largest polypeptide synthesized that is immunoprecipitable by T antibody has a molecular weight of about 60,000 (27, 28, 33 ). Yet, with the early 20S mRNA from SV40-infected cells as message in the wheat germ cell-free system, a T antibody-precipitable polypeptide with a molecular weight of 94,000 is synthesized (6, 27) . This is the apparent molecular weight of in vivo T antigen (6, 35) . Thus, with both polyoma cRNA and SV40 cRNA, the major translation products are prematurely terminated fragments, although in the case of polyoma cRNA some full-length viral proteins are synthesized.
Similar experiments on the translation of mRNA (26) and of cRNA, using linked transcription/translation (29, 31) , have been reported by using the closely related virus SV40. From all these results, it is clear that the structural proteins VP1, VP2, and VP3 of both polyoma and SV40 are coded for by the viral DNA. 
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